1. SARS-CoV-2 and probable lung cancer risk

Sajad Khiali , Afra Rezagholizadeh , Taher Entezari-Maleki*

BioImpacts. 2022;12(3): 291-292. doi: 10.34172/bi.2022.23266

PMCID: PMC9124879 PMID: 35677665 Scopus ID: 85132071249

Article

PDF

Full Text

XML

Cited By:

In the present perspective piece, three possible mechanisms of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an oncogenic virus in the lung have been discussed.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons